Search results for:
bendamustine
bendamustine
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Bendamustine (Bendeka) |
SOLUTION, INTRAVENOUS |
25 mg/mL (4 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Apr. 15, 2025
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
System Formulary Restriction:
Bendamustine orders must be signed by a Hematology/Oncology Attending Physician
Med Center
UNC Medical Center Formulary Restrictions